G1 Therapeutics Inc (NAS:GTHX)
$ 7.15 0 (0%) Market Cap: 377.22 Mil Enterprise Value: 364.45 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 31/100

G1 Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript

Jun 22, 2021 / 01:20PM GMT
Release Date Price: $21.36 (-0.79%)
Dane Leone
Raymond James Financial, Inc. - Analyst

Welcome, everyone, to day 2 of the Raymond James 2021 Human Health Innovation Conference. My name is Dane Leone, one of the senior biotech analysts at the Raymond James team. For this session, we are going to have a fireside chat with the leadership team of G1 Therapeutics. The ticker is GTHX. Very excited to have the CEO, Jack Bailey, with me; and Rajesh Malik, who is the CMO. Gentlemen, thank you so much for joining us. Looking forward to the discussion today.

Just want to set the stage for maybe some of the audience members that don't know your team as well. If you could just give a brief introduction on yourself, backgrounds, and then we can get some Qs about what you guys are working on over at G1.

Jack Bailey
G1 Therapeutics, Inc - CEO

Sounds good. Thanks for having us, Dane. We couldn't be more excited to be here. My name is Jack Bailey, as you mentioned, the CEO of G1. It was announced last fall. I had the opportunity to have the transition with my predecessor during the fall and then

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot